Learn More
Enzo Life Sciences SUPERFASLIGAND Protein (soluble) (human), (recombinant) (5 µg)

Supplier: Enzo Life Sciences ALX522020C005
Fas ligand with improved stability providing significantly enhanced immune activation. Alternative name: FasL (oligomer), APO-1L (oligomer), CD95L (oligomer), CD178 (oligomer), TNFSF 6 (oligomer). MW: ~32kDa (nonglycosylated), ~35kDa (glycosylated). Concentration: 0.1mg/ml after reconstitution. Endotoxin content: <0.1EU/µg purified protein (LAL test; Associates of Cape Cod). Purity: ≥95% (SDS-PAGE). Formulation: Lyophilized. Contains PBS. Source: Produced in HEK 293 cells. The extracellular domain of human FasL (APO-1L; CD95L; CD178) (aa 103-281) is fused at the N-terminus to a linker peptide (26 aa) and a FLAG-tag. Glycosylation of rhs SUPERFASLIGAND is similar to natural human FasL. Specificity: Binds to human, mouse and rat Fas (CD95; APO-1). Use/Stability: Stable for at least 6 months after receipt when stored at -20°C. UniProt: P48023. Application: ELISA. Handling: Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. Long Term Storage: -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.